Interference with immunofixation in a dabigatran-overdosed patient treated with idarucizumab: beware of a diagnostic pitfall

Articles in the same Issue

1. Frontmatter
2. Editorial
3. The European Health Data Space: challenges and opportunities for laboratory medicine
4. Review
5. Saliva sampling matters for salivary diagnostics of viral infections
6. Opinion Papers
7. Mass spectrometry based precision diagnostics: on the cusp of selective testing
8. Supporting trend detection in the cumulative display of electronic laboratory reports from multiple laboratories while preserving measurement provenance
9. Secondary use of external quality assessment data – estimating inter-assay variation in LOINC-coded datasets
10. Methodological evaluation and clinical interpretation of hs-cTnI and hs-cTnT variations: a reappraisal
11. Point of care testing of biochemical markers for monitoring astronauts during long duration missions in deep space
12. EFLM Paper
13. Strategy of Laboratory Medicine – EFLM Vision
14. Guidelines and Recommendations
15. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part III: Clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometry
16. Genetics and Molecular Diagnostics
17. Optimization and comparison of genomic DNA extraction from whole blood collected in PAXgene blood RNA tube using automated platforms
18. Small-scale external quality assessment of methylated SHOX2 and RASSF1A detection in China: findings from 2023–2024
19. General Clinical Chemistry and Laboratory Medicine
20. Development and validation of a machine learning model for accurate detection of wrong blood in tube errors in hospitalized patients
21. Short- and medium-term pre-analytical stability of human serum insulin-like growth factor-1
22. Creatinine measurement from finger stick dried blood spots with a routine chemistry analyzer for estimation of GFR
23. Towards a global framework of entrustable professional activities for undergraduate clinical laboratory interns: a competency-based approach
24. Spot urine is a suitable matrix for measurement of copeptin
25. Reference Values and Biological Variations
26. Use of indirect methods and machine learning algorithms for the estimation of reference intervals, taking cortisol measurements as an example
27. ReferenceRangeR: a novel tool designed to facilitate reference interval estimation and verification
28. VeRUS: verification of reference intervals based on the uncertainty of sampling
29. Hematology and Coagulation
30. Hemolysis index. Can we uncritically trust manufacturer declarations?
31. Cancer Diagnostics
32. Thresholds adjustments and impact on clinical performance of three FIT assays in a colorectal cancer screening program
33. A robust ddPCR assay for the absolute quantification of miR-192-5p in hepatocellular carcinoma liquid biopsies
34. Pro-gastrin releasing peptide as a tumor marker of medullary thyroid carcinoma: a comparative bivariate meta-analysis
35. Infectious Diseases
36. Prognostic utility of serial procalcitonin measurements in ICU sepsis: a laboratory-led modelling approach in a resource-limited setting procalcitonin modelling for sepsis mortality in a low-resource ICU
37. Letters to the Editor
38. Biological variation of serum transthyretin concentrations
39. Pitfalls of immunoassays for diagnosis of hypoglycemia of undetermined etiology
40. Cross reactivity of endogenous and exogenous 25-hydroxyvitamin D₂ in commercial vitamin D assays; an evaluation using the Dutch external quality assessment scheme
41. Interference with immunofixation in a dabigatran-overdosed patient treated with idarucizumab: beware of a diagnostic pitfall
42. Potential savings of two practical interventions on vitamin D ordering practices at a large academic medical center
43. Familial erythrocytosis and phenotypic heterogeneity associated with different defects in alpha globin genes: a significant new case of Hb Wroclaw (α88(F9) Ala>Glu; HBA1: c.266C>A)
44. ROTEM-guided diagnostic pathway in a centralized Laboratory Medicine setting: an organizational report